跳至主要内容
临床试验/EUCTR2010-023208-29-DE
EUCTR2010-023208-29-DE进行中(未招募)1 期

Effects of Oxytocin on opioide withdrawal symptoms

Rheinische Friedrich-Wilhelms-University of Bonn0 个研究点目标入组 80 人开始时间: 2010年12月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • 80 Male volunteers with opioid dependency who are voluntary inpatients from detoxification unit
  • 18 to 65 years
  • Capable of legally effective informed condsent and persons not being in legal custody
  • Given written-informed consent to the study procedures
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Lack of legally effective informed consent
  • Contraindication of MRI
  • Axis I disorder
  • Acute polytoxikomania
  • Cerebrale abnormality (diagnosed by MRI)
  • status post organ transplantation
  • Known allergic to oxytoocin of alkyl-4-hydroxybenzoate
  • Consumption of large amounts of fluid before oxytocin application
  • Water and electrolyte dysbalance
  • Severe renal insufficiency
  • Decompensated cirrhosis of the liver (Ascites, vaiceal haemorrhage, encephalopathy)

研究者

发起方
Rheinische Friedrich-Wilhelms-University of Bonn

相似试验